Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 12Thoracic 6Endocrine 3Head & Neck 2Breast 2Sarcoma 1Other solid neoplasm 1NET 1

Conditions

Thyroid Neoplasms 1Head and Neck Cancers - Salivary Gland 1

Interventions

Cisplatin 108Radiotherapy 45Docetaxel 44Radiotherapy, Intensity-Modulated 36Gemcitabine 31Fluorouracil 30camrelizumab 24toripalimab 21Drug Therapy 21Cetuximab 20apatinib 19Paclitaxel 16Carboplatin 16pembrolizumab 14Chemoradiotherapy 14Capecitabine 13Blood Specimen Collection 13sintilimab 12nimotuzumab 12Surveys and Questionnaires 10Surgical Procedures, Operative 10Endostatins 10Cyclophosphamide 9nedaplatin 8endostar protein 8durvalumab 8Nivolumab 8Neoadjuvant Therapy 8Induction Chemotherapy 8fludarabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × surufatinib × Head & Neck × Clear all
NCT04910854 2021-06-02

Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 2 Unknown
27 enrolled
Head & Neck

Head and Neck Cancers - Salivary Gland

NCT04524884 2020-08-24

Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study

Fudan University

Phase 2 Unknown
10 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡